Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review.

Autor: Bodagh N; King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. neil.bodagh@kcl.ac.uk., Yap R; Princess Royal University Hospital, Orpington, UK., Kotadia I; King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.; Guys and St. Thomas' NHS Foundation Trust, London, UK., Sim I; King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK., Bhalla A; Guys and St. Thomas' NHS Foundation Trust, London, UK., Somerville P; Guys and St. Thomas' NHS Foundation Trust, London, UK., O'Neill M; King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.; Guys and St. Thomas' NHS Foundation Trust, London, UK., Williams SE; King's College London, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Jazyk: angličtina
Zdroj: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing [J Interv Card Electrophysiol] 2022 Oct; Vol. 65 (1), pp. 271-286. Date of Electronic Publication: 2022 Apr 05.
DOI: 10.1007/s10840-022-01196-y
Abstrakt: Purpose: Atrial fibrillation is associated with an increased risk of cognitive impairment. It is unclear whether the restoration of sinus rhythm with catheter ablation may modify this risk. We conducted a systematic review of studies comparing cognitive outcomes following catheter ablation with medical therapy (rate and/or rhythm control) in atrial fibrillation.
Methods: Searches were performed on the following databases from their inception to 17 October 2021: PubMed, OVID Medline, Embase and Cochrane Library. The inclusion criteria comprised studies comparing catheter ablation against medical therapy (rate and/or rhythm control in conjunction with anticoagulation where appropriate) which included cognitive assessment and/or a diagnosis of dementia as an outcome.
Results: A total of 599 records were screened. Ten studies including 15,886 patients treated with catheter ablation and 42,684 patients treated with medical therapy were included. Studies which compared the impact of catheter ablation versus medical therapy on quantitative assessments of cognitive function yielded conflicting results. In studies, examining new onset dementia during follow-up, catheter ablation was associated with a lower risk of subsequent dementia diagnosis compared to medical therapy (hazard ratio: 0.60 (95% confidence interval 0.42-0.88, p < 0.05)).
Conclusion: The accumulating evidence linking atrial fibrillation with cognitive impairment warrants the design of atrial fibrillation treatment strategies aimed at minimising cognitive decline. However, the impact of catheter ablation and atrial fibrillation medical therapy on cognitive decline is currently uncertain. Future studies investigating atrial fibrillation treatment strategies should include cognitive outcomes as important clinical endpoints.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: